Results 61 to 70 of about 8,939,854 (208)
Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia
Philadelphia‐negative myeloproliferative neoplasms (MPNs) are significantly associated with the development of splanchnic vein thrombosis, which leads to portal hypertension.
Jiacheng Liu, Xiaoming Liu, Bin Xiong
doaj +1 more source
ABSTRACT Post‐hepatectomy bile leak is a common postoperative complication. It usually resolves spontaneously but may be refractory. In cases of completely disconnected bile ducts, endoscopic retrograde cholangiopancreatography (ERCP)–guided drainage is often technically difficult, and invasive additional procedures may be required.
Tatsuki Tanaka +9 more
wiley +1 more source
Transfemoral hepatic vein catheterization reduces procedure time in double vein embolization
Background Double vein embolization with simultaneous embolization of the portal and hepatic vein aims to grow the future liver remnant in preparation for major hepatectomy. Transvenous hepatic vein embolization is usually done via a transjugular access.
Dominik A. Steffen +2 more
doaj +1 more source
The purpose of the study was to compare the methods of mechanical reduction of blood flow in the right branch of the portal vein: portal vein embolization (PVE) and portal vein ligation (PVL) as a neoadjuvant treatment before extended hepatectomy to ...
K. K. Ladyk +2 more
doaj +1 more source
Congenital portosystemic shunt (CPS) is a developmental anomaly of the portal vein system. The disease can cause blood from the portal vein to flow into the vena cava, resulting in various atypical clinical manifestations. Pelvic congestion syndrome (PCS)
Wei Zheng +3 more
doaj +1 more source
Portal Vein Embolization: History and Current Indications [PDF]
Portal vein embolization (PVE) was first adapted for patients undergoing major hepatectomy for hepatocellular carcinoma (HCC). In these patients, PVE caused hypertrophy of the unaffected liver and increased the volumetric ratio of future liver remnant (FLR) to total liver volume.
Hiroji Shinkawa +3 more
openaire +2 more sources
ABSTRACT Background To evaluate whether the albumin–bilirubin (ALBI) grade modifies the association of combined locoregional plus systemic therapy versus systemic therapy alone with outcomes in unresectable hepatocellular carcinoma (HCC). Methods This multicente retrospective study enrolled 525 patients, stratified by the established ALBI grade cut‐off
Kang Liang +9 more
wiley +1 more source
Portal vein embolization with different embolic agents for right hepatectomy
Background/aims: We aimed to retrospectively evaluate our experience in portal vein embolization that induces hypertrophy of the future liver remnant before right hepatectomy and to determine the differences in outcome with respect to the embolic agents ...
BALKANCI, FERHUN +16 more
core +1 more source
In blunt abdominal trauma, the prevalence of superior mesenteric vein injury or portal vein injury is low and surgical treatment is often difficult. We report a case of percutaneous transhepatic embolization in a patient who experienced isolated rupture
Hoon Kwon +5 more
doaj +1 more source
ABSTRACT Severe future liver remnant (FLR) deficiency frequently renders giant hepatocellular carcinoma (HCC) unresectable. We report a 48‐year‐old man with an unresectable 23.5‐cm giant HCC (Couinaud segments 4/5/8; baseline serum alpha‐fetoprotein (AFP), 1036.65 μg/L).
Qing Ye +5 more
wiley +1 more source

